| Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small … H Linardou, IJ Dahabreh, D Kanaloupiti, F Siannis, D Bafaloukos, ... The lancet oncology 9 (10), 962-972, 2008 | 948 | 2008 |
| Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ... American journal of respiratory and critical care medicine 184 (1), 132-140, 2011 | 402 | 2011 |
| Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials IJ Dahabreh, H Linardou, F Siannis, G Fountzilas, S Murray The oncologist 13 (6), 620-630, 2008 | 330 | 2008 |
| Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC H Linardou, IJ Dahabreh, D Bafaloukos, P Kosmidis, S Murray Nature reviews Clinical oncology 6 (6), 352-366, 2009 | 295 | 2009 |
| Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies S Murray, E Briasoulis, H Linardou, D Bafaloukos, C Papadimitriou Cancer treatment reviews 38 (7), 890-903, 2012 | 291 | 2012 |
| Guidance for laboratories performing molecular pathology for cancer patients IA Cree, Z Deans, MJL Ligtenberg, N Normanno, A Edsjö, E Rouleau, ... Journal of clinical pathology 67 (11), 923-931, 2014 | 218 | 2014 |
| Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non–small cell lung cancer IJ Dahabreh, H Linardou, F Siannis, P Kosmidis, D Bafaloukos, S Murray Clinical Cancer Research 16 (1), 291-303, 2010 | 214 | 2010 |
| Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical … S Murray, IJ Dahabreh, H Linardou, M Manoloukos, D Bafaloukos, ... Journal of thoracic oncology 3 (8), 832-839, 2008 | 173 | 2008 |
| Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer DH Roukos, S Murray, E Briasoulis Cancer biology & therapy 6 (3), 308-312, 2007 | 143 | 2007 |
| The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy SE Pinder, S Murray, IO Ellis, H Trihia, CW Elston, RD Gelber, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 142 | 1998 |
| BMP induced inflammation: A comparison of rhBMP‐7 and rhBMP‐2 KB Lee, CE Taghavi, SS Murray, KJ Song, G Keorochana, JC Wang Journal of Orthopaedic Research 30 (12), 1985-1994, 2012 | 110 | 2012 |
| EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer IJ Dahabreh, H Linardou, P Kosmidis, D Bafaloukos, S Murray Annals of oncology 22 (3), 545-552, 2011 | 102 | 2011 |
| ‘Classical’but not ‘other’mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer AG Pallis, A Voutsina, A Kalikaki, J Souglakos, E Briasoulis, S Murray, ... British journal of cancer 97 (11), 1560-1566, 2007 | 98 | 2007 |
| Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker … G Fountzilas, M Bobos, A Kalogera-Fountzila, N Xiros, S Murray, ... Cancer investigation 26 (8), 784-793, 2008 | 96 | 2008 |
| All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer H Linardou, E Briasoulis, IJ Dahabreh, G Mountzios, C Papadimitriou, ... Cancer treatment reviews 37 (3), 221-233, 2011 | 83 | 2011 |
| Guideline on the requirements of external quality assessment programs in molecular pathology JH Van Krieken, N Normanno, F Blackhall, E Boone, G Botti, F Carneiro, ... Virchows Archiv 462, 27-37, 2013 | 82 | 2013 |
| Somatic mutations of adenomatous polyposis coli gene and nuclear b‐catenin accumulation have prognostic significance in invasive urothelial carcinomas: evidence for Wnt pathway … E Kastritis, S Murray, F Kyriakou, M Horti, N Tamvakis, N Kavantzas, ... International journal of cancer 124 (1), 103-108, 2009 | 80 | 2009 |
| Genotype Misclassification in Genetic Association Studies of the rs1042522 TP53 (Arg72Pro) Polymorphism: A Systematic Review of Studies of Breast, Lung … IJ Dahabreh, CH Schmid, J Lau, V Varvarigou, S Murray, TA Trikalinos American journal of epidemiology 177 (12), 1317-1325, 2013 | 71 | 2013 |
| What’s in a task? Complications in the study of the task-unrelated-thought variety of mind wandering S Murray, K Krasich, JW Schooler, P Seli Perspectives on Psychological Science 15 (3), 572-588, 2020 | 70 | 2020 |
| TP53 Arg72Pro Polymorphism and Colorectal Cancer Risk: A Systematic Review and Meta-Analysis IJ Dahabreh, H Linardou, P Bouzika, V Varvarigou, S Murray Cancer epidemiology, biomarkers & prevention 19 (7), 1840-1847, 2010 | 53 | 2010 |
